Overexpression of Smac/DIABLO in Hep-2 cell line: Possible role in potentiating the sensitivity of chemotherapeutic drugs

Tumori

Volumn 96, Issue 2, 2010, Pages 310-315

  Lu, Sumei ^a   Xu, Wei ^a   Fan, Zhaomin ^a   Liu, Wenwen ^a   Li, Jianfeng ^a   Wang, Haibo ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Chemotherapy; Hep 2 cells; Smac DIABLO; Synergistic effect

Indexed keywords

CASPASE 3; CASPASE 9; CISPLATIN; FLUOROURACIL; MESSENGER RNA; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; FLOW CYTOMETRY; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LARYNX CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 77952935575     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600220     Document Type: Article

References (19)

1. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA: Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope, 116: 1-13, 2006. (Pubitemid 44337830)
2. Friboulet L, Pioche-Durieu C, Rodriguez S, Valent A, Souquère S, Ripoche H, Khabir A, Tsao SW, Bosq J, Lo KW, Busson P: Recurrent over-expression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis. Neoplasia, 10: 1183-1194, 2008.
3. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. PNAS, 104: 973-978, 2007.
4. Lefebvre JL, Ang KK: Larynx Preservation Consensus Panel: Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Int J Radiat Oncol Biol Phys, 73: 1293-1303, 2009.
5. Agrawal N, Goldenberg D: Primary and salvage total laryngectomy. Otolaryngol Clin North Am, 41: 771-780, 2008.
6. Malet-Martino M, Martino R: Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. Oncologist, 7: 288-323, 2002. (Pubitemid 34919955)
7. Sánchez Romero JA, Ramírez Ruiz F, Romero Fernández L, Pastor Gaitán P, Murillo Capitán E: Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder. Actas Urol Esp, 13: 240-242, 1989.
8. Rudolf E, Rudolf K, Cervinka M: Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol Toxicol, 24: 123-141, 2008. (Pubitemid 351311388)
9. Gradzka I: Mechanisms and regulation of the programmed cell death. Postepy Biochem, 52: 157-165, 2006.
10. Salvesen GS, Duckett CS: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol, 3: 401-410, 2002.
11. Deveraux QL, Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev, 13: 239-252, 1999.
12. Augello C, Caruso L, Maggioni M, Donadon M, Montorsi M, Santambrogio R, Torzilli G, Vaira V, Pellegrini C, Roncalli M, Coggi G, Bosari S: Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer, 9: 125, 2009.
13. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102: 43-53, 2000.
14. Fu J, Jin Y, Arend LJ: Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein. J Biol Chem, 278: 52660-52672, 2003. (Pubitemid 38035863)
15. Fandy TE, Shankar S, Srivastava RK: Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol Cancer, 7: 1-10, 2008.
16. Li L, Jiang AC, Dong P, Wang H, Xu W, Xu C: MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Ann Surg Oncol, 16: 1421-1428, 2009.
17. Dai Y, Liu M, Tang W, DeSano J, Burstein E, Davis M, Pienta K, Lawrence T, Xu L: Molecularly targeted radio sensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin Cancer Res, 14: 7701-7710, 2008.
18. Korga A, Korobowicz E, Dudka J: Role of mitochondrial protein Smac/Diablo in regulation of apoptotic pathways. Pol Merkur Lekarski, 20: 573-578, 2006.
19. Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J: Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res, 27: 48, 2008.